Clinical Trial

Insights on Dissemination of Lung Cancer

Study acronym: LUCID
Recruiting
View on ClinicalTrials.gov →
Summary
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Trial Details
NCT Number NCT07476495
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Oncology & Epidemiology & Lung Cancer
Enrollment 100 participants
Start Date 2026-02-01
Primary Completion 2029-02-01 (estimated)
Study Completion 2029-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-17